Preventability of severe acute maternal morbidity

May 11, 2017 by in GYNECOLOGY Comments Off on Preventability of severe acute maternal morbidity

Objective We sought to assess potential preventability of severe acute maternal morbidity (SAMM) cases admitted to intensive-care units (ICUs) or high-dependency units (HDUs). Study Design Inclusion criteria were admissions to…

read more

A fetal cardiovascular score to predict infant hypertension and arterial remodeling in intrauterine growth restriction

May 11, 2017 by in GYNECOLOGY Comments Off on A fetal cardiovascular score to predict infant hypertension and arterial remodeling in intrauterine growth restriction

Objective Intrauterine growth restricted (IUGR) fetuses experience cardiovascular remodeling that persists into infancy and has been related to cardiovascular outcomes in adulthood. Hypertension in infancy has been demonstrated to be…

read more

Cardiac dysfunction is associated with altered sarcomere ultrastructure in intrauterine growth restriction

May 11, 2017 by in GYNECOLOGY Comments Off on Cardiac dysfunction is associated with altered sarcomere ultrastructure in intrauterine growth restriction

Objective The purpose of this study was to assess whether abnormal cardiac function in human fetuses with intrauterine growth restriction (IUGR) is associated with ultrastructural differences in the cardiomyocyte sarcomere….

read more

ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model

May 11, 2017 by in GYNECOLOGY Comments Off on ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model

Objective Protease-activated receptor 2 plays an important role in the pathogenesis of endometriosis. We studied the effect of ENMD-1068, a protease-activated receptor 2 antagonist, on the development of endometriosis in…

read more

The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model

May 11, 2017 by in GYNECOLOGY Comments Off on The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model

Objective Preeclampsia alters fetal programming and results in long-term metabolic consequences in the offspring. Pravastatin has been shown to prevent preeclampsia in animal models. Our aim was to characterize the…

read more
Get Clinical Tree app for offline access